Insperity, Inc. (NSP) Q2 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call presents a mixed picture: strong client retention and efficient sales are positive, but reduced growth guidance and declining gross profit per employee are concerns. The Q&A reveals optimism about future growth and strategic initiatives, yet lacks concrete guidance on the Workday partnership's financial impact. The partnership with Workday and share repurchases provide some optimism, but increased healthcare costs and uncertain future projections temper enthusiasm. Given the market cap of $3.44 billion, the stock price is likely to remain stable, resulting in a neutral prediction.
Key Financial Performance
EPS (Earnings Per Share) Second quarter EPS was $0.26, which fell slightly under the low end of the forecasted range by $0.03 per share due to higher-than-expected benefits costs.
Adjusted EBITDA Adjusted EBITDA for Q2 2025 was $32 million, which was $1 million below the low end of the forecasted range, primarily due to higher-than-expected benefits costs.
Average Paid Worksite Employees The average number of paid worksite employees increased by 0.7% year-over-year to 309,115 in Q2 2025. This growth was within the forecasted range and reflects sales efficiency improvements and strong client retention.
Gross Profit Per Worksite Employee Gross profit per worksite employee in Q2 2025 was $240 per month, down from $282 in Q2 2024. The decline was due to unfavorable health care claims development in 2025 compared to favorable claims development in 2024.
Benefits Costs Per Covered Employee Benefits costs per covered employee increased by 9.6% year-over-year in Q2 2025. This was driven by higher pharmacy costs, increased utilization of specialty drugs, and a modest increase in incurred but not reported claims.
Operating Expenses Operating expenses decreased by 3% year-over-year in Q2 2025, with significant reductions in travel, professional fees, and other G&A costs.
Dividends Paid The company paid $22 million in cash dividends during Q2 2025 and $45 million year-to-date.
Stock Repurchase 224,000 shares of stock were repurchased at a cost of $19 million year-to-date.
Adjusted Cash The company ended Q2 2025 with $114 million of adjusted cash and $280 million available under its credit facility.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Insperity HRScale: A new joint offering developed through a strategic partnership with Workday. It integrates Workday Human Capital Management into Insperity's HR service and technology platform. Beta clients are expected to go live early next year, with further client onboarding planned for 2026.
Updated HR solution portfolio: Rebranded flagship PEO service as Insperity HR 360, traditional employment solution as Insperity HR Core, and introduced Insperity HRScale. These solutions aim to address specific HR management needs and expand the total addressable market.
Insperity Contractor Management powered by Wingspan: A recent addition to the product portfolio aimed at solving complex challenges for businesses and improving employee lives.
Market expansion through HRScale: Targeting mid-market companies with a focus on affordability, ease of deployment, and scalability. Market research indicates strong receptivity and premium pricing potential for HRScale.
Sales efficiency improvement: Achieved a 13% improvement in sales efficiency in Q2 2025 with 11% fewer trained Business Performance Advisors.
Operating expense management: Operating expenses decreased by 3% year-over-year, with reductions in travel, professional fees, and G&A costs. Continued investment in strategic priorities like the Workday partnership.
AI development: Focused on improving efficiency, value, productivity, and quality of services. AI tools are being used by client-facing HR professionals.
Pricing and plan design changes: Implemented higher pricing targets and plan design changes to mitigate rising benefits costs. These measures are expected to improve profitability in 2026.
Workday strategic partnership: Invested $14 million in Q2 2025. The partnership aims to co-develop HRScale and expand market reach.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Higher-than-expected benefits costs: The company experienced higher-than-expected benefits costs, including a $12 million increase in Q2 2025. This was driven by higher pharmacy costs, increased utilization of specialty drugs, and a rise in incurred but not reported claims. These trends have significantly impacted earnings in 2025.
Elevated large claim frequency: Large claim frequency remained elevated, with cancer and heart-related conditions showing the largest year-over-year increases. This poses a risk to the company's financial performance.
Economic uncertainties: The market faced economic uncertainties, impacting sales and client hiring trends. Net hiring within the client base, while slightly improved, remains below historical norms.
Insurance carrier publicity issues: Challenges stemming from specific insurance carrier publicity issues in Q2 affected the company's operations and market perception.
Macroeconomic conditions: Macroeconomic factors such as tariffs, inflation, and interest rates have created a complex and shifting market landscape, impacting small- and medium-sized businesses and, consequently, the company's growth.
Contract renewal with UHC: The ongoing contract extension discussions with UHC are critical, particularly in addressing elevated pharmacy cost trends and the expanding use of specialty drugs. Any unfavorable outcomes could impact cost management.
Sales force reduction: The sales team is 11% smaller than the previous year, which could limit the company's ability to capitalize on growth opportunities despite improved sales efficiency.
Implementation of Workday partnership: The implementation of the Workday strategic partnership involves risks, including potential delays in the go-live date for Insperity HRScale beta clients. Any delays could impact the company's strategic objectives and market positioning.
Operating expense management: While operating expenses have been managed below budget, there is ongoing pressure to balance cost reductions with investments in strategic priorities, such as marketing and the Workday partnership.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue and Worksite Employee Growth: Forecasting full-year worksite employee growth of 1% to 2% over 2024. Q3 2025 average paid worksite employees expected to range between 312,200 and 315,300, representing a 1% to 2% increase over Q3 2024.
Benefits Cost Trends: Raising forecasted range of benefits cost per covered employee by 75 to 100 basis points for the full year. Benefits cost trend expected to taper down from 9% experienced in the first half of 2025 due to favorable changes in plan demographics and migration.
Adjusted Financial Metrics: Full-year adjusted EBITDA forecasted in the range of $170 million to $205 million. Full-year adjusted EPS forecasted in the range of $1.81 to $2.51. Q3 2025 adjusted EBITDA expected to range between $24 million and $44 million, with adjusted EPS between $0.06 and $0.49.
Profitability Improvement Plans: Plans to drive significant profitability improvement in 2026 through pricing increases, benefit plan design changes, and contract renewal negotiations with UHC. Pricing measures expected to accumulate impact in the second half of 2025 and continue into 2026.
Strategic Partnership with Workday: Target go-live date for Insperity HRScale beta clients set for early 2026, with additional clients expected to adopt later in 2026. Joint go-to-market plan with Workday initiated, including co-selling discovery calls and pricing strategy development.
Operating Expense Management: Operating expenses expected to decline slightly sequentially in each remaining quarter of 2025. Full-year operating expenses projected to decrease compared to 2024, despite planned spending on Workday partnership and additional marketing for fall sales campaign.
Market Conditions and SMB Outlook: Belief that recent federal legislation supporting small businesses may catalyze expansion in the SMB community, potentially moving hiring trends back to historical levels in 2026.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Regular Dividend Program: During the second quarter, the company paid $22 million in cash dividends. On a year-to-date basis, $45 million in cash dividends have been paid.
Share Repurchase Program: The company repurchased 224,000 shares of stock at a cost of $19 million on a year-to-date basis.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What is the expected financial impact of Workday in 2026?
A:Management is excited about the progress but stated it is too early to precisely predict the revenue and profitability impact. They are currently working on pricing strategies and have received positive feedback on the value of their service components. They plan to finalize pricing and client group strategies over the next quarter.
Q:Has there been any improvement in net client hiring and WSEE dynamics?
A:Management noted an improvement in underlying hiring levels, although still below historical levels. They observed positive movement and expressed optimism about future growth, despite not budgeting significant improvements for the remainder of the year.
Q:Is the original $150 million investment in Workday still appropriate, and what is the visibility into associated expenses?
A:Management believes the $150 million investment remains appropriate but expects the total investment to slightly exceed this amount over five years. They anticipate a reduction in income statement impact as expenses become capitalizable closer to launch. Early phases will involve operational inefficiencies, but they expect growing efficiency over time.
Q:What is the expected margin profile of the business after the Workday implementation?
A:Management expects the margin profile to improve over time due to higher retention rates, larger client acquisitions, and better pricing. They anticipate enhanced operating leverage and higher prices for larger clients, although it is too early to provide specific numbers.
Q:How does management view the joint marketing launch and its impact on client acquisition?
A:Management is optimistic about the joint marketing launch, emphasizing the strong demand for integrated HR services and technology. They believe the partnership with Workday will attract clients who see value in the combined offering, even if it takes time to implement.
Q:What is the outlook for BPA growth over the next 12-24 months?
A:Management expects nominal growth in the BPA base but anticipates significant efficiency gains. They plan to grow worksite employee units more rapidly with fewer BPAs, leveraging improved sales efficiency.
Q:What is the strategy for addressing rising healthcare costs?
A:Management plans to address rising healthcare costs primarily through pricing adjustments. They are also negotiating structural changes with UnitedHealthcare to mitigate future cost increases and improve plan design.
Q:What is the timeline for broad-scale marketing of the Workday solution?
A:Management did not provide a specific timeline but indicated that the focus will initially be on beta clients and refining the solution. Broad-scale marketing may occur after these phases, potentially in late 2026.
Q:What are the potential outcomes of renegotiations with UnitedHealthcare?
A:Management aims to align incentives with UnitedHealthcare to manage costs and grow together. They are focused on structuring the relationship to benefit plan participants, which they believe will also benefit Insperity and UnitedHealthcare in the long run.
Q:What is the range of outcomes for healthcare cost trends in 3Q and 2025?
A:Management expects healthcare cost trends to normalize slightly from the 9% year-to-date increase but remain 75-100 basis points higher than their prior forecast. They are focused on annual trends rather than quarterly fluctuations.
Q:Review of Unclear Management Responses
A:Management avoided providing specific financial projections for the Workday initiative in 2026, citing the early stage of development. They also did not commit to a timeline for broad-scale marketing of the Workday solution, leaving the exact timing uncertain.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI capability
Advisors
Co
HR solution
HRScale client
Insperity HR
Insperity HRScale
LLC Research
PEO client
Research Division
UHC
agility
challenge
contract
date plan
design change
discovery
drug
employee Insperity
enablement
experience period
fee
focus
framework
increase sale
insurance carrier
map
market research
negotiation
outlook profitability
pharmacy
plan balance
portfolio
premium
productivity
recovery plan
sale retention
service technology
solution Insperity
tenant
NSP Transcript
Insperity, Inc. (NSP) Q1 2026 Earnings Call Transcript
Unknown5-1
The earnings call reflects a mixed sentiment. While the company is optimistic about HRScale's potential and profit recovery, there are challenges like lowered guidance and competitive pricing pressures. The Q&A reveals cautious optimism, with no significant negative surprises but also no strong positive catalysts. The market cap suggests moderate stock volatility. Given the mixed financial performance and guidance, the stock price is expected to remain relatively stable over the next two weeks, resulting in a neutral sentiment rating.
Insperity, Inc. (NSP) Q4 2025 Earnings Call Transcript
Unknown2-10
The earnings call summary presents a mixed outlook. While there are positive elements like the HRScale rollout and strategic partnerships, concerns about elevated benefits costs, uncertain client transitions, and a lack of specific guidance on profitability metrics temper enthusiasm. The Q&A section highlights management's reluctance to provide specific details, adding to uncertainty. Given the company's mid-cap size, these factors suggest a neutral stock price reaction in the short term.
Insperity, Inc. (NSP) Q3 2025 Earnings Call Transcript
Unknown11-4
The earnings call revealed disappointing financial results with an EPS miss and lower EBITDA due to high benefits costs. Despite a positive outlook for 2026, the immediate financials are concerning. The Q&A highlighted management's optimism about future recovery and strong sales, but did not address current issues effectively. With a market cap of ~$3.4 billion, the negative financial results and uncertainty in guidance are likely to lead to a negative stock price movement in the short term.
Insperity, Inc. (NSP) Q2 2025 Earnings Call Transcript
Unknown8-1
The earnings call presents a mixed picture: strong client retention and efficient sales are positive, but reduced growth guidance and declining gross profit per employee are concerns. The Q&A reveals optimism about future growth and strategic initiatives, yet lacks concrete guidance on the Workday partnership's financial impact. The partnership with Workday and share repurchases provide some optimism, but increased healthcare costs and uncertain future projections temper enthusiasm. Given the market cap of $3.44 billion, the stock price is likely to remain stable, resulting in a neutral prediction.
NSP Slides
Insperity Q1 2026 slides: margin recovery gains amid worksite employee decline2026-04-30
Insperity Q4 2025 slides: Profit slump drives recovery focus for 20262026-02-10
Insperity Q3 2025 slides: Benefits costs weigh on earnings despite employee growth2025-11-03
Insperity Q2 2025 slides: Earnings plunge 70% despite worksite employee growth2025-08-01
NSP Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
